CFI provides innovative emergency management solutions for federal, state, and local governments, as well as the private sector. Their software solutions help public health officials prepare for emergencies, coordinate response efforts, and build stronger communities. CFI’s CORES Platform offers interoperability, performance, security, and usability that exceed industry standards.
Andy Nunemaker, President of the Intermedix EMSystems Division commented, “Bringing together the robust technology and innovative leadership of our two companies redefines what is possible in the emergency preparedness and response industry. This combination will not only benefit our client base, but will benefit the industry as a whole and the communities they serve.”
Doug Shamon, President and CEO of Intermedix Corporation stated, “Our goal at Intermedix is to effectively meet the needs of the emergency community today, while continually seeking solutions for tomorrow. The acquisition of CFI is clearly another step toward building upon our market leadership in taking a holistic approach to improving the US emergency healthcare system.”
According to Atila Omer, CEO of Collaborative Fusion, Inc., “All of us at CFI see an opportunity, combined with Intermedix EMSystems, to better serve our existing clients and to bring new emergency preparedness and public health solutions to the market. Intermedix has demonstrated a strong commitment to the industry, and we are proud to now be a part of such a dedicated team.”
Intermedix is a global leader pioneering innovations in technology and analytics to deliver best-in-class revenue cycle management and practice management solutions. The company enables more than 15,000 health care providers to focus on delivering excellence in patient care. In May 2018, Intermedix was officially acquired by the publicly-held company R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care.